Knockout of miR-221 and miR-222 reveals common and specific targets for paralogous miRNAs

被引:11
|
作者
Jeong, Geon [1 ,2 ,3 ]
Lim, Yeong-Hwan [1 ,2 ,3 ]
Kim, Nam Joong [1 ,2 ,3 ]
Wee, Gabbine [4 ]
Kim, Young-Kook [1 ,2 ,3 ]
机构
[1] Chonnam Natl Univ, Dept Biochem, Sch Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Ctr Creat Biomed Scientists, Sch Med, Gwangju, South Korea
[3] Chonnam Natl Univ, Basic Res Lab Cardiac Remodeling, Sch Med, Gwangju, South Korea
[4] Daegu Gyeongbuk Med Innovat Fdn, Daegu, South Korea
基金
新加坡国家研究基金会;
关键词
Knockout; microRNA; miR-221; miR-222; TALEN; CARCINOMA-CELL-LINES; MICRORNAS; P27(KIP1); CANCER;
D O I
10.1080/15476286.2016.1269994
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) regulate the expression of mRNA through sequence-specific binding of the 3 untranslated region (UTR). The seed sequence of miRNAs is the key determinant for target site recognition. Paralogous miRNAs, which share the same seed sequences but differ in their 3 regions, are known to regulate largely overlapping groups of mRNAs. However, no study has analyzed functional differences between paralogous miRNAs with proper experimental methods. In this study, we compared the targets of paralogous miRNAs, miR-221 and miR-222. Using a nuclease-mediated genome engineering technique, we established knockout cell lines for these miRNAs, and precisely analyzed differences in target regulation. We found that miR-221 and miR-222 suppress the previously identified targets, CDKN1B and CDKN1C, differentially. Whereas both miRNAs suppressed CDKN1B, only miR-221 suppressed CDKN1C. From transcriptome analyses, we found that several different target mRNAs were regulated by each of miR-221 and miR-222 independently, although a large number of mRNAs responded commonly to miR-221 and miR-222. This is the first study to compare the mRNA regulations by paralogous miRNAs and illustrate that paralogous miRNAs with the same seed sequence also have difference in target regulation.
引用
收藏
页码:197 / 205
页数:9
相关论文
共 50 条
  • [41] New molecular biomarkers in differentiated thyroid carcinoma: Impact of miR-146, miR-221 and miR-222 levels in the evolution of the disease
    Maria Gomez-Perez, Ana
    Cornejo Pareja, Isabel Maria
    Garcia Aleman, Jorge
    Coin Araguez, Leticia
    Sebastian Ochoa, Arantzazu
    Alcaide Torres, Juan
    Molina Vega, Maria
    Clu Fernandez, Carlos
    Mancha Doblas, Isabel
    Tinahones, Francisco J.
    CLINICAL ENDOCRINOLOGY, 2019, 91 (01) : 187 - 194
  • [42] miR-21, miR-221 and miR-222 expression and prostate cancer recurrence among obese and non-obese cases
    Amankwah, Ernest K.
    Anegbe, Evelyn
    Park, Hyun
    Pow-Sang, Julio
    Hakam, Ardeshir
    Park, Jong Y.
    ASIAN JOURNAL OF ANDROLOGY, 2013, 15 (02) : 226 - 230
  • [43] MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells
    Yang, Y.
    Zhao, X.
    Li, H. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2016, 20 (08) : 1509 - 1515
  • [44] miR-221/miR-222在人甲状腺乳头状癌中的表达增加
    王俊
    颜秉菊
    罗英
    基础医学与临床, 2016, 36 (03) : 391 - 392
  • [45] MiR-221/miR-222在甲状腺乳头状癌中的表达及意义
    梁润
    云耀峰
    内蒙古医学杂志, 2020, 52 (10) : 1231 - 1232
  • [46] Efficacy of DMBG and gemcitabine as a combination treatment on advanced pancreatic cancer, and their effect on miR-190, miR-196a, miR-221 and miR-222
    Li, Chuanbao
    Ni, Lina
    Cui, Xijun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2020, 13 (02): : 582 - 589
  • [47] Adenovirus-mediated shRNAs for co-repression of miR-221 and miR-222 expression and function in glioblastoma cells
    Wang, Xuan
    Han, Lei
    Zhang, Anling
    Wang, Guangxiu
    Jia, Zhifan
    Yang, Yang
    Yue, Xiao
    Pu, Peiyu
    Shen, Changhong
    Kang, Chunsheng
    ONCOLOGY REPORTS, 2011, 25 (01) : 97 - 105
  • [48] MiR-221 and miR-222 regulate cell cycle progression and affect chemosensitivity in breast cancer by targeting ANXA3
    Kim, Ju-Yeon
    Jung, Eun Jung
    Kim, Jae-Myung
    Son, Youngsim
    Lee, Han Shine
    Kwag, Seung-Jin
    Park, Ji-Ho
    Cho, Jin-Kyu
    Kim, Han-Gil
    Park, Taejin
    Jeong, Sang-Ho
    Jeong, Chi-Young
    Ju, Young-Tae
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (03)
  • [49] miR-221/miR-222与c-Kit在重度子痫前期的表达及意义
    秦薇
    高洁
    赣南医学院学报, 2015, 35 (06) : 887 - 890
  • [50] Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation
    le Sage, Carlos
    Nagel, Remco
    Egan, David A.
    Schrier, Mariette
    Mesman, Elly
    Mangiola, Annunziato
    Anile, Corrado
    Maira, Giulio
    Mercatelli, Neri
    Ciafre, Silvia Anna
    Farace, Maria Giulia
    Agami, Reuven
    EMBO JOURNAL, 2007, 26 (15): : 3699 - 3708